Adsett Roger — SEC Form 4 filings
SEC reporting owner CIK 1685904. 24 Form 4 filings on record with FilingPulse; latest filed 2026-08-12.
Transaction summary — filings shown
Covers all 24 filings on record, filed 2024-01-05 to 2026-08-12. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 33 legs across 19 filings — 516,984 shares, $61,841,946 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 25.
- Largest priced transaction: sale of 239,850 shares @ $133.27 ($31,964,810) in INSMED Inc, filed 2026-08-12.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| INSMED Inc (INSM) | Chief Operating Officer | 21 | — | 33 legs · 516,984 sh · $61,841,946 | 19 |
| Definium Therapeutics, Inc. (DFTX) | Director | 2 | — | — | 3 |
| Landos Biopharma, Inc. (LABP) | Director | 1 | — | — | 3 |
Form 4 filings — Adsett Roger
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-12 | 4 | INSMED Inc (INSM) | Option exercise (M): 82,280 @ $13.67 · Option exercise (M): 76,600 @ $17.16 · Option exercise (M): 80,970 @ $30.46 · Sale (S): 239,850 @ $133.27 · Option exercise (M): 82,280 (derivative) @ $0 · Option exercise (M): 76,600 (derivative) @ $0 · +1 more | EDGAR |
| 2026-06-15 | 4 | Definium Therapeutics, Inc. (DFTX) | Grant/award (A): 3,555 @ $0 · Grant/award (A): 14,620 (derivative) @ $0 | EDGAR |
| 2026-06-05 | 4 | INSMED Inc (INSM) | Sale (S): 2,370 @ $102.27 | EDGAR |
| 2026-05-15 | 4 | INSMED Inc (INSM) | Sale (S): 5,837 @ $116.18 | EDGAR |
| 2026-04-03 | 4 | INSMED Inc (INSM) | Option exercise (M): 88,060 @ $14.56 · Sale (S): 6,715 @ $163.18 · Sale (S): 19,001 @ $164.11 · Sale (S): 62,344 @ $164.95 · Option exercise (M): 88,060 (derivative) @ $0 | EDGAR |
| 2026-02-04 | 4 | INSMED Inc (INSM) | Sale (S): 791 @ $156.17 | EDGAR |
| 2026-01-29 | 4 | Definium Therapeutics, Inc. (DFTX) | Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2026-01-08 | 4 | INSMED Inc (INSM) | Sale (S): 1,429 @ $173.33 · Sale (S): 802 @ $175.07 · Sale (S): 2,059 @ $174.17 | EDGAR |
| 2026-01-06 | 4 | INSMED Inc (INSM) | Grant/award (A): 5,998 · Grant/award (A): 31,280 (derivative) @ $0 | EDGAR |
| 2025-08-21 | 4 | INSMED Inc (INSM) | Sale (S): 20,193 @ $127.42 · Sale (S): 4,807 @ $128.27 | EDGAR |
| 2025-06-18 | 4 | INSMED Inc (INSM) | Sale (S): 6,500 @ $98.50 · Sale (S): 4,186 @ $99.32 | EDGAR |
| 2025-06-04 | 4 | INSMED Inc (INSM) | Sale (S): 1,860 @ $71.50 | EDGAR |
| 2025-05-19 | 4 | INSMED Inc (INSM) | Grant/award (A): 6,508 @ $0 · Grant/award (A): 31,610 (derivative) @ $0 | EDGAR |
| 2025-05-15 | 4 | INSMED Inc (INSM) | Sale (S): 7,482 @ $67.81 · Sale (S): 1,925 @ $65.61 | EDGAR |
| 2025-02-12 | 4 | INSMED Inc (INSM) | Sale (S): 11,053 @ $77.02 · Sale (S): 5,781 @ $78.36 · Sale (S): 26,141 @ $79.33 | EDGAR |
| 2025-02-07 | 4 | INSMED Inc (INSM) | Grant/award (A): 88,680 @ $0 · Sale (S): 45,605 @ $80.90 · Sale (S): 100 @ $79.57 | EDGAR |
| 2025-01-16 | 4 | INSMED Inc (INSM) | Sale (S): 1,457 @ $68.72 | EDGAR |
| 2025-01-10 | 4 | INSMED Inc (INSM) | Sale (S): 2,444 @ $65.95 · Sale (S): 1,882 @ $66.10 · Grant/award (A): 6,657 · Sale (S): 1,298 @ $63.86 · Sale (S): 3,604 @ $63.62 · Grant/award (A): 31,930 (derivative) @ $0 | EDGAR |
| 2024-05-23 | 4 | Landos Biopharma, Inc. (LABP) | Disposition to issuer (D): 1,800 (derivative) · Disposition to issuer (D): 1,800 (derivative) · Disposition to issuer (D): 3,600 (derivative) | EDGAR |
| 2024-05-17 | 4 | INSMED Inc (INSM) | Sale (S): 5,945 @ $25.09 | EDGAR |
| 2024-05-15 | 4 | INSMED Inc (INSM) | Grant/award (A): 14,518 · Sale (S): 7,857 @ $25.50 · Grant/award (A): 71,160 (derivative) @ $0 | EDGAR |
| 2024-01-12 | 4 | INSMED Inc (INSM) | Sale (S): 5,251 @ $28.63 | EDGAR |
| 2024-01-11 | 4 | INSMED Inc (INSM) | Sale (S): 3,837 @ $29.25 · Sale (S): 3,536 @ $28.90 | EDGAR |
| 2024-01-05 | 4 | INSMED Inc (INSM) | Grant/award (A): 12,873 · Sale (S): 3,042 @ $29.21 · Grant/award (A): 63,560 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-04 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1685904 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →